National Health Investors, Inc. (NYSE:NHI) Given Average Recommendation of “Moderate Buy” by Analysts

National Health Investors, Inc. (NYSE:NHI) has been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $86.6667.

Several equities analysts have issued reports on NHI shares. Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Monday. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Truist Financial dropped their price target on National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd.

National Health Investors Price Performance

National Health Investors stock opened at $68.49 on Friday. The stock’s 50 day moving average is $78.59 and its 200 day moving average is $80.38. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The firm has a market cap of $3.32 billion, a P/E ratio of 22.09, a P/E/G ratio of 3.63 and a beta of 0.52. National Health Investors has a one year low of $67.94 and a one year high of $91.38.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.39). National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The business had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. During the same period last year, the firm posted $1.15 earnings per share. National Health Investors’s quarterly revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts expect that National Health Investors will post 5.07 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a yield of 5.4%. National Health Investors’s payout ratio is 118.71%.

Institutional Investors Weigh In On National Health Investors

Several hedge funds and other institutional investors have recently modified their holdings of NHI. Norges Bank bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $55,301,000. JPMorgan Chase & Co. increased its holdings in shares of National Health Investors by 34.0% during the third quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after acquiring an additional 409,559 shares in the last quarter. Freestone Grove Partners LP bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $21,869,000. Adage Capital Partners GP L.L.C. bought a new stake in shares of National Health Investors during the fourth quarter valued at approximately $19,856,000. Finally, Balyasny Asset Management L.P. increased its holdings in shares of National Health Investors by 66.9% during the second quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after acquiring an additional 246,486 shares in the last quarter. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.